Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

Inclusion Criteria: * Female patients, age 9-26 years, with polyarticular JIA, pauciarticular JIA, and sero-negative arthritis. Exclusion Criteria: * Pregnancy * Known allergy/sensitivity or any hypersensitivity to yeast or components of study drug or their formulation * Systemic onset JIA with active systemic symptoms (systemic onset JIA with polyarticular features but no fever or rash may be included). * Prior vaccination against HPV * Known HPV infection * Current or history of cervical cancer or cervical intraepithelial neoplasia (CIN). Males are excluded from this study because Gardasil® is currently approved only for females.